For the Inventor, By the Inventor

Enter assignee name

Sunnyvale, CA, United States of America

Centaur Pharmaceuticals, Inc.

USPTO Granted Patents = 35

% Expired Patents = 2.9

Forward Citations = 147

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Allan L Wilcox (23 out of 34 patents)

William D Flitter (18 out of 20 patents)

William A Garland (17 out of 19 patents)

4. Yong-Kang Zhang (12 out of 60 patents)

5. Kirk R Maples (12 out of 37 patents)

6. Richard E Paylor (12 out of 14 patents)

7. Judith A Kelleher (11 out of 11 patents)

8. Ian Irwin (6 out of 10 patents)

9. Beverly Greenwood Van-Meerveld (5 out of 5 patents)

10. John M Carney (4 out of 21 patents)

11. Lowell David Waterbury (4 out of 4 patents)

12. Julian Levell (3 out of 3 patents)

13. Alina Dykman (3 out of 3 patents)

14. Hong Xu (3 out of 3 patents)

15. Kenneth W Narducy (3 out of 3 patents)

35 patents: Sort by Forward Citations

1. 6545056 - Aryl nitrone therapeutics and methods for treating inflammatory bowel disease (2003-04-08),

2. 6509378 - Acetamidobenzamide compounds for neurodegenerative disorders (2003-01-21),

3. 6486349 - Amide therapeutics and methods for treating inflammatory bowel disease (2002-11-26),

4. 6441032 - Alpha-(4-Ethoxyphenyl)-N-tert-butylnitrone, pharmaceutical compositions and their medical use (2002-08-27),

5. 6433008 - &agr;-aryl-N-alkylnitrones and pharmaceutical compositions containing the same (2002-08-13),

6. 6376540 - Furan nitrone compounds (2002-04-23),

7. 6342523 - 3,4,5-trisubstituted aryl nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation (2002-01-29),

8. 6310092 - Methods for preventing and treating autoimmune and inflammatory disease using thioether furan nitrone compounds (2001-10-30),

9. 6271265 - Amide therapeutics for the treatment of inflammatory bowel disease (2001-08-07),

10. 6258852 - Aryl nitrone therapeutics for the treatment of inflammatory bowel disease (2001-07-10),

11. 6255353 - Inhibition of angiogenesis (2001-07-03),

12. 6197826 - &agr;-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation (2001-03-06),

13. 6194465 - Benzamide therapeutics for the treatment of inflammatory bowel disease (2001-02-27),

14. 6140369 - Benzamides for neurodegenerative disorder treatment (2000-10-31),

15. 6140356 - Opthalmic pharmaceutical compositions comprising a nitrone compound and (2000-10-31),

Centaur Pharmaceuticals is a leading Indian pharmaceutical company that specializes in manufacturing high-quality generic and branded medicines. With over four decades of experience in the industry, Centaur Pharmaceuticals has established a strong presence in both domestic and international markets. The company is committed to delivering affordable healthcare solutions to patients worldwide and has a diverse product portfolio that caters to various therapeutic segments. Centaur Pharmaceuticals ensures strict adherence to quality standards and regulatory requirements, making it a trusted name in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Centaur Pharmaceuticals, Inc.

35 Patents

#127 in Sunnyvale, CA

#2,305 in California

#9,734 in US

#19,126 in the World

Sunnyvale, CA, United States of America

Centaur Pharmaceuticals, Inc.

Forward Citations = 147

20 inventors:

Allan L Wilcox (23 out of 34 patents)

William D Flitter (18 out of 20 patents)

William A Garland (17 out of 19 patents)

4. Yong-Kang Zhang (12 out of 60 patents)

5. Kirk R Maples (12 out of 37 patents)

Please report any incorrect information to [email protected]

Loading…